Regulus Therapeutics  logo
Regulus Therapeutics RGLS
$ 1.46 -6.41%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Regulus Therapeutics Operating Cash Flow 2011-2024 | RGLS

Annual Operating Cash Flow Regulus Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-26.8 M -25.5 M -24.1 M -12.5 M -19.8 M -43.3 M -58.8 M -56.9 M -49.9 M -39.5 M -28.3 M -8.72 M -15.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-8.72 M -58.8 M -31.5 M

Quarterly Operating Cash Flow Regulus Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- -8.74 M - - - -8.11 M - - -12.5 M -6.38 M - - -10.7 M -5.71 M - -15.7 M -11.2 M -6 M - -14.8 M -10.1 M -4.43 M - -39.3 M -27.8 M -15.6 M - -47.7 M -36 M -18.7 M - -41.8 M -26.3 M -8.93 M - -32.8 M -21 M -11.3 M - - - -9.03 M - - - -7.16 M - -9.57 M -9.8 M -5.13 M - -9.58 M - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-4.43 M -47.7 M -16.4 M